| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Mar 16, 2023 | Mar 17, 2023 | Goodson Jason Daniel EVP Head of Corp Development | Buy | $8.38 | $9,493 | +2.85% |
| Mar 14, 2023 | Mar 16, 2023 | Sulat James R Dir | Buy | $8.48 | $254,475 | +26.65% |
| Mar 14, 2023 | Mar 16, 2023 | Bisaro Paul Dir | Buy | $8.47 | $42,330 | +6.26% |
| Mar 13, 2023 | Mar 15, 2023 | Welch Stephen Andrew EVP Head of Spec Generics | Buy | $8.48 | $8,480 | +2.53% |
| Mar 13, 2023 | Mar 15, 2023 | Olafsson Sigurdur O Pres CEO | Buy | $8.37 | $25,121 | +1.30% |
| Jun 07, 2019 | Jun 07, 2019 | Reasons Bryan M. EVP CFO | Buy | $8.96 | $48,383 | +23.10% |
| May 30, 2019 | May 31, 2019 | Trudeau Mark Pres CEO | Buy | $9.26 | $18,528 | +0.85% |
| May 09, 2019 | May 10, 2019 | Trudeau Mark Pres CEO | Buy | $16.33 | $16,325 | +0.43% |
| Mar 05, 2019 | Mar 06, 2019 | Trudeau Mark Pres CEO | Buy | $22.65 | $22,650 | +0.43% |
| Dec 10, 2018 | Dec 11, 2018 | Trudeau Mark Pres CEO | Buy | $20.18 | $20,180 | +0.42% |
| May 16, 2018 | May 18, 2018 | Trudeau Mark Pres CEO | Buy | $15.54 | $46,615 | +1.10% |
| May 09, 2018 | May 10, 2018 | Flynn James E *Possible member of 10% group 10% | Sell | $13.39 | $4M | -3.63% |
| Nov 28, 2017 | Nov 30, 2017 | Youngblood Dr Kneeland Dir | Buy | $21.94 | $100,046 | +18.73% |
| Nov 14, 2017 | Nov 15, 2017 | Watkins Ian J CHRO | Buy | $21.08 | $42,156 | +6.55% |
| Nov 14, 2017 | Nov 15, 2017 | O'Neill Hugh M. EVP Pres ARD | Buy | $21.8 | $196,200 | +18.26% |
| Nov 13, 2017 | Nov 13, 2017 | Booth Melvin D Dir | Buy | $21.82 | $218,236 | +19.32% |
| Nov 13, 2017 | Nov 13, 2017 | Zaccagnino Joseph A Dir | Buy | $21.3 | $106,500 | +16.10% |
| Nov 13, 2017 | Nov 13, 2017 | Gulyas Diane H. Dir | Buy | $21.3 | $31,950 | +7.00% |
| Nov 13, 2017 | Nov 13, 2017 | Reed Joann A Dir | Buy | $21.5 | $21,500 | +6.04% |
| Nov 13, 2017 | Nov 13, 2017 | Romano Steven J. EVP Chief Sci. Ofcr | Buy | $21.96 | $43,920 | +7.62% |
| Nov 09, 2017 | Nov 13, 2017 | Carroll J Martin Dir | Buy | $20.42 | $102,094 | +17.51% |
| Nov 10, 2017 | Nov 13, 2017 | Trudeau Mark Pres CEO | Buy | $22.28 | $111,402 | +1.82% |
| Nov 10, 2017 | Nov 13, 2017 | Norton David Y Dir | Buy | $22.02 | $44,030 | +20.83% |
| Nov 09, 2017 | Nov 13, 2017 | Hicks Michael-Bryant GC | Buy | $20.8 | $164,309 | +31.97% |
| Nov 09, 2017 | Nov 13, 2017 | Carlucci David R Dir | Buy | $21.83 | $218,349 | +27.76% |
| Aug 30, 2017 | Sep 01, 2017 | Fischer Meredith B Chief Public Affairs Officer | Buy | $39.63 | $50,725 | +4.27% |
| Jun 09, 2017 | Jun 12, 2017 | Lannum Coleman N III SVP Investor Strategy IRO | Buy | $39.83 | $117,503 | +7.54% |
| Jun 08, 2017 | Jun 12, 2017 | O'Neill Hugh M. EVP Pres ARD | Buy | $40.24 | $40,237 | +3.12% |
| Jun 09, 2017 | Jun 12, 2017 | Trudeau Mark Pres CEO | Buy | $40.17 | $40,174 | +0.38% |
| Jun 09, 2017 | Jun 12, 2017 | Lloyd Ronald K. EVP Pres Hospital | Buy | $41.26 | $206,320 | +21.77% |